Prevail Therapeutics advances development of PR-001 for Parkinson's and Gaucher's diseases Sep. 12, 2019
FDA approves Xeris' Gvoke, first ready-to-use stable liquid glucagon for severe hypoglycemia Sep. 12, 2019
Phio Pharmaceuticals enters agreement with Carisma Therapeutics to enhance adoptive cell therapy Sep. 12, 2019
RSS